FDA approves Ipsen's ultra-rare disease drug palovarotene
The FDA gave a nod of approval to Ipsen’s treatment for the ultra-rare disease fibrodysplasia ossificans progressiva though regulators have expressed concerns at least twice …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
